Skip to content

Efficacy and Mechanisms of Non-invasive Brain-Computer Interface Combined with Acupuncture for Subacute Post-Stroke Dysphagia: An EEG-fNIRS Multimodal Assessment Study

Efficacy and Mechanisms of Non-invasive Brain-Computer Interface Combined with Acupuncture for Subacute Post-Stroke Dysphagia: An EEG-fNIRS Multimodal Assessment Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001464
Enrollment
Unknown
Registered
2026-06-10
Start date
2026-06-09
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Stroke Dysphagia

Interventions

Brain-Computer Interface Group:On the basis of basic treatments-including medication (for secondary prevention, improving cerebral circulation, neuroprotection, and muscle relaxation), as well as limb
Brain-Computer Interface Combined with Acupuncture Group:On the basis of basic treatments (medication for secondary prevention, improving cerebral circulation, neuroprotection, and muscle relaxation
plus limb acupuncture, limb physical/occupational therapy, and swallowing rehabilitation [behavioral therapy + feeding training], all administered once daily for 30 min per session, 5 days/week for 3 

Sponsors

Guangdong Provincial Second Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1)Meet the diagnostic criteria for stroke and present with dysphagia. (2)Aged 18 to 80 years, with no gender restriction. (3)Time from stroke onset between 1 week and 1 month. (4)Alert and without cognitive impairment (Minimum Mental State Examination [MMSE] score = 24). (5)Willing to participate in the clinical study voluntarily, with informed consent signed by the patient or their legal guardian.

Exclusion criteria

Exclusion criteria: (1)True bulbar palsy. (2)Unstable vital signs, including but not limited to: concomitant severe organic diseases of the heart, liver, kidney or other organs; malignant tumors; psychiatric disorders; or active intracerebral hemorrhage/new cerebral infarction. (3)Presence of any risk factors for EEG/functional electrical stimulation, including but not limited to:Electrically, magnetically or mechanically activated metallic or non-metallic implants (e.g., cardiac pacemaker, intracranial vascular clips);Local skin or muscle injury at the intended electrode placement site, or sensory disturbances with decreased or increased sensitivity to electrical stimulation;Traumatic brain injury or defects, damage, infection or other severe infections at the site of cranial intervention;History of epilepsy or post-stroke seizures. (4)Organic lesions of the oral cavity, pharynx or esophagus, or dysphagia caused by other reasons. (5)Pregnant or breastfeeding women.

Design outcomes

Primary

MeasureTime frame
Penetration-Aspiration Scale,PAS;

Secondary

MeasureTime frame
Yale pharyngeal residue severity rating scale, YPR-SRS;Modified Mann Assessment of Swallowing Ability, MASA;functional oral intake scale,FOIS;EEG-fNIRS multimodal data assessment;Clinical efficacy assessment;

Countries

China

Contacts

Public ContactLiu Tong

Guangdong Provincial Second Hospital of Traditional Chinese Medicine

liutongmama@163.com+8618319673139

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 29, 2026